Skip to main content
. 2005 Apr;59(4):387–397. doi: 10.1111/j.1365-2125.2005.02333.x

Table 2.

Reproducibility of baseline measurements and forearm blood flow (FBF) responses

Baseline measurement Mean difference (95% CI) Repeatability coefficient WCV (%) (95% CI) ICC
SBP (mmHg) 2.3 (−4.8, 9.5) 13.4 4 (1–8) 0.57 (−0.45, 0.94)
DBP (mmHg) 3.3 (−1.7, 8.4) 9.5 4 (1–7) 0.42 (−0.59, 0.92)
Heart rate (bpm) −1.0 (−6.3, 4.3) 10.0 6 (1–12) 0.90 (0.31, 0.99)
FBFinfused (ml min−1 dl−1 forearm) −0.4 (−1.5, 0.8) 2.2 27 (5–49) 0.70 (−0.26, 0.96)
FBFnon-infused (ml min−1 dl−1 forearm) 0.2 (−0.6, 0.9) 1.4 23 (4–41) 0.36 (−0.64, 0.91)
FBF-ratio −0.1 (−0.5, 0.3) 0.7 20 (4–36) 0.68 (−0.29, 0.96)
FBF response Method of data expression Mean difference (95% CI) Repeatability coefficient WCV (%) ICC
FBF45 FBFinfused 0.3 (−1.9, 2.4) 4.1 11 (2–19) 0.82 (0.02, 0.95)
FBF-ratio −0.7 (−4.1, 2.7) 6.4 37 (7–66) −0.22 (−0.88, 0.72)
FBFinfused% 29 (−154, 212) 342 29 (5–52) 0.56 (−0.46, 0.94)
FBF-ratio% −8 (−253, 237) 458 40 (7–72) 0.24 (−0.71, 0.88)
AUC0−45 FBFinfused 15 (−81, 110) 178 12 (2–22) 0.78 (−0.07, 0.98)
FBF-ratio 4 (−83, 90) 162 26 (5–46) 0.18 (−0.74, 0.87)
FBFinfused% 1613 (−3932, 7158) 10 359 25 (5–45) 0.56 (−0.46, 0.94)
FBF-ratio% 2144 (−3908, 8197) 11 307 26 (5–47) 0.24 (−0.71, 0.88)
ΔFBF0−45 FBFinfused 0.6 (−1.7, 3.0) 4.4 14 (3–25) 0.75 (−0.15, 0.97)
FBF-ratio −0.6 (−3.8, 2.6) 6.0 43 (8–77) −0.23 (−0.88, 0.71)
FBFinfused% 29 (−154, 212) 342 29 (5–52) 0.56 (−0.46, 0.94)
FBF-ratio% −8 (−253, 237) 458 40 (7–72) 0.24 (−0.71, 0.88)

WCV, within-subject coefficient of variation; ICC, intraclass correlation coefficient; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBFinfused, forearm blood flow in the infused arm; FBFnon-infused, forearm blood flow in the noninfused arm; FBF-ratio, ratio of forearm blood flow between the infused and noninfused arm. FBF45, FBF at 45 min; AUC0−45, the area under the curve from baseline to 45 min; ΔFBF0−45, change in FBF from baseline to 45 min. FBF response is expressed as: (1) FBFinfused (ml min−1 dl−1 forearm) (2) FBF-ratio (3) percentage change from baseline in FBF in the infused arm (FBFinfused%,%) and (4) percentage change from baseline in FBF-ratio (FBF-ratio%, %).